|
In vivo response of P. falciparum to SP during the extended period of follow up after cessation of sIPT implementation per age categories and treatment group |
||||||
| 1–4 years |
5–11 years |
All |
||||
|
|
|
|
||||
| Outcome |
sIPT- (n = 102) |
sIPT + (n = 104) |
sIPT- (n = 130) |
sIPT + (n = 136) |
sIPT- (n = 232) |
sIPT + (n = 240) |
|
|
||||||
| ACPR |
87.3 |
84.6 |
88.5 |
93.4 |
87.9 |
89.6 |
| ETF |
0.0 |
1.0 |
1.5 |
0.7 |
0.9 |
0.8 |
| LCF |
1.0 |
0.0 |
0.0 |
0.0 |
0.4 |
0.0 |
| LPF |
11.8 |
14.4 |
10.0 |
5.9 |
10.8 |
9.6 |
|
sIPT - = control group sIPT + = treatment group ACPR = adequate clinical and parasitological response ETF = early treatment failure LPF = late parasitological failure | ||||||
Dicko et al. Malaria Journal 2008 7:123 doi:10.1186/1475-2875-7-123 |
||||||